Thoracic oncology in Europe: The ERS action plan by the Thoracic Oncology Assembly

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1227-1228

  Sculier, J P ^a   Vansteenkiste, J ^b   Schonfeld N ^c   Scherpereel, A ^d  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^d UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER THERAPY; CLINICAL RESEARCH; CONTINUING EDUCATION; EDITORIAL; EUROPEAN RESPIRATORY SOCIETY; HEALTH CARE QUALITY; LUNG CANCER; MALIGNANT MESOTHELIOMA; MEDIASTINUM TUMOR; MEDICAL EDUCATION; MEDICAL SOCIETY; PLEURA MESOTHELIOMA; POSTGRADUATE EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; THORAX CANCER;

EID: 78649747794     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00146810     Document Type: Editorial

References (7)

1. La Vecchia C, Bosetti C, Lucchini F, et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2010; 21: 1323-1360.
2. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
3. Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34: 17-41.
4. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35: 479-495.
5. Blum T, Schönfeld N, Kollmeier J, et al. Lungenkrebs in Deutschland - zur Versorgungslage der Nation. Pneumologie 2010; 64: 1-12.
6. Scherpereel A, Berghmans T, Lafitte JJ, et al. Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study. Eur Respir J 2010 [Epub ahead of print DOI: 10.1183/09031936.00037310].
7. Van Schil PE, Baas P, Gaafar R, et al. Phase II trial of trimodality therapy for malignant pleural mesothelioma (EORTC 08031). Eur Respir J 2010 [Epub ahead of print DOI: 10.1183/09031936.00039510].